Sanara MedTech Inc. (SMTI) reported higher revenue in the second quarter of 2026, with total sales rising to $28.1 million, up 8.9% from a year earlier. Gross profit also improved, climbing to $26.2 million as the company continued to post strong top-line growth.
Profitability was more mixed. Operating profit came in at $1.8 million, while net income attributable to common shareholders was a loss of $452,864, or $(0.05) per diluted share. Cash from operating activities totaled $2.0 million, down from the prior-year period.
On the balance sheet, Sanara MedTech ended the quarter with $15.4 million in cash and cash equivalents, and total liabilities stood at $61.2 million. Cost of sales increased modestly to $2.0 million, while spending on property and equipment remained minimal.
- Revenue: $28.1 million, up 8.9%
- Gross profit: $26.2 million, up 9.5%
- Operating profit: $1.8 million
- Net loss attributable to common shareholders: $(452,864)
- Cash and cash equivalents: $15.4 million
Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.
Sanara MedTech Inc. Hedge Fund Activity
We have seen 43 institutional investors add shares of Sanara MedTech Inc. stock to their portfolio, and 20 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BAIRD FINANCIAL GROUP, INC. removed 739,218 shares (-97.2%) from their portfolio in Q1 2026, for an estimated $12,699,765
- AQR CAPITAL MANAGEMENT LLC added 39,938 shares (+inf%) to their portfolio in Q1 2026, for an estimated $686,134
- WALLEYE CAPITAL LLC added 30,465 shares (+inf%) to their portfolio in Q2 2026, for an estimated $718,669
- MARSHALL WACE, LLP added 27,671 shares (+56.9%) to their portfolio in Q1 2026, for an estimated $475,387
- RENAISSANCE TECHNOLOGIES LLC added 27,078 shares (+72.0%) to their portfolio in Q1 2026, for an estimated $465,200
- QUBE RESEARCH & TECHNOLOGIES LTD added 26,409 shares (+inf%) to their portfolio in Q1 2026, for an estimated $453,706
- EVERNEST FINANCIAL ADVISORS, LLC added 25,700 shares (+inf%) to their portfolio in Q2 2026, for an estimated $606,263
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
Sanara MedTech Inc. Price Targets
Multiple analysts have issued price targets for $SMTI recently. We have seen 2 analysts offer price targets for $SMTI in the last 6 months, with a median target of $33.5.
Here are some recent targets:
- Ilya Zubkov from Freedom Broker set a target price of $35.0 on 06/17/2026
- Frank Takkinen from Lake Street set a target price of $32.0 on 04/15/2026
